CRISPR NEWS

U.S. Court of Appeals for the Federal Circuit schedules oral hearing for April 30

The U.S. Court of Appeals for the Federal Circuit has scheduled an oral hearing for April 30 in the appeal brought by the Doudna-Charpentier team of the February 2017 Patent Trial and Appeal Board (PTAB) ruling. The appeal asks that the court reinstate the interference proceeding that was terminated by the PTAB.

To read about the possible outcomes of the appeal, read: Doudna-Charpentier team appeals the PTAB decision to the U.S. Court of Appeals for the Federal Circuit (CAFC) requesting that the decision to terminate be overturned

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issued U.S. Patent No. 10,266,850 (‘the ‘850 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier
European Patent Office (EPO) awarded the Doudna-Charpentier team a broad CRISPR-Cas9 patent (EP Patent No. 3 401 400)
U.S. patent office issued third CRISPR patent to CVC; indicates it will issue a fourth
Read moreArrow-down